Research published today in Clinical and Experimental Immunology shows that a peptide (small protein) called PEPITEM could provide a revolutionary approach to reducing the risk of type 2 diabetes and other obesity-related ...
Mar 9, 2023
0
26
Patients with severe eczema who were treated with the drug dupilumab experienced a reduction in symptoms and improved quality of life, according to a meta-analysis of several clinical trials published in JAMA Dermatology.
Mar 2, 2023
0
94
The human immune system is incredibly versatile. Among its most skilled multitaskers are T cells, known for their role in everything from fighting infection to reining in inflammation to killing nascent tumors.
Mar 2, 2023
0
70
Immune cells that keep the brain free of debris but also contribute to inflammation are the likely culprits behind the concentration and memory problems that sometimes follow one type of chemotherapy, a new study in mice ...
Feb 28, 2023
0
38
Hypertension, or high blood pressure, tops the list of chronic health conditions. It affects about one-third of the world's population, including nearly 44 percent of German citizens. If the pressure in the blood vessels ...
Feb 23, 2023
0
21
Every year, thousands of babies in Germany are born many weeks too early and often have to struggle for months. The earlier the babies are born, the higher the risk of life-threatening complications. Infections can lead to ...
Feb 22, 2023
0
6
A new research paper titled "Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer" has been published in Oncotarget.
Feb 14, 2023
0
18
As we age, the end caps of our chromosomes, called telomeres, gradually shorten. Now, Salk scientists have discovered that when telomeres become very short, they communicate with mitochondria, the cell's powerhouses. This ...
Feb 8, 2023
0
323
A common sign of Alzheimer's disease is the excessive buildup of two types of protein in the brain: tangles of tau proteins that accumulate inside cells, and amyloid-β proteins that form plaques outside the cells. Researchers ...
Feb 2, 2023
0
471
Patients with glioblastoma—the deadliest type of primary brain tumor—may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response against cancer cells.
Feb 2, 2023
0
30
